US FDA advisory panel sets stage for Moderna vaccine authorisation
Published
The committee voted 20-0 with one abstention that the benefits of the vaccine outweigh its risks in people aged 18 and older.
Full ArticlePublished
The committee voted 20-0 with one abstention that the benefits of the vaccine outweigh its risks in people aged 18 and older.
Full ArticleWatch VideoThe FDA is poised to approve a second COVID vaccine soon.
A government advisory panel endorsed the one from..
German stocks edged higher on Friday after Moderna's coronavirus vaccine won backing from a panel of experts who advise the U.S...